Brian L Fish
Overview
Explore the profile of Brian L Fish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1063
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wesolowski R, Fish B, Eibl M, Bahr S, Munjal Mehta S, Czajkowski M, et al.
Int J Radiat Biol
. 2024 Nov;
101(1):1-14.
PMID: 39531584
Repurposing therapeutic agents with existing clinical data is a common strategy for developing radiation countermeasures. IEPA (imidazolyl ethanamide pentandioic acid) is an orally bioavailable small molecule pseudopeptide with myeloprotective properties,...
2.
Kondelaji M, Sharma G, Jagtap J, Shafiee S, Hansen C, Gasperetti T, et al.
Mol Imaging Biol
. 2023 Aug;
26(1):124-137.
PMID: 37530966
Purpose: Vascular endothelium plays a central role in the pathogenesis of acute and chronic radiation injuries, yet the mechanisms which promote sustained endothelial dysfunction and contribute to late responding organ...
3.
Cohen E, Fish B, Medhora M
Int J Radiat Biol
. 2023 May;
99(7):991-993.
PMID: 37172306
No abstract available.
4.
Medhora M, Gao F, Gasperetti T, Narayanan J, Himburg H, Jacobs E, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982722
Currently, there are no biomarkers to predict lethal lung injury by radiation. Since it is not ethical to irradiate humans, animal models must be used to identify biomarkers. Injury to...
5.
Andruska N, Schlaak R, Frei A, Schottstaedt A, Lin C, Fish B, et al.
Int J Radiat Biol
. 2023 Mar;
99(7):1096-1108.
PMID: 36971580
Purpose: Radiation therapy remains part of the standard of care for breast, lung, and esophageal cancers. While radiotherapy improves local control and survival, radiation-induced heart dysfunction is a common side...
6.
Bansal S, Bansal S, Fish B, Li Y, Xu X, Fernandez J, et al.
Int J Radiat Biol
. 2023 Feb;
99(7):1109-1118.
PMID: 36827630
Purpose: The goal of the current study was to identify longitudinal changes in urinary metabolites following IR exposure and to determine potential alleviation of radiation toxicities by administration of recombinant...
7.
Fish B, Hart B, Gasperetti T, Narayanan J, Gao F, Veley D, et al.
Int J Radiat Biol
. 2023 Feb;
99(7):1119-1129.
PMID: 36794325
Purpose: To test IPW-5371 for the mitigation of the delayed effects of acute radiation exposure (DEARE). Survivors of acute radiation exposure are at risk for developing delayed multi-organ toxicities; however,...
8.
Gasperetti T, Frei A, Sharma G, Pierce L, Veley D, Szalewski N, et al.
Int J Radiat Biol
. 2023 Jan;
99(7):1130-1138.
PMID: 36688956
Purpose: A mass casualty disaster involving radiological or nuclear agents continues to be a public health concern which requires consideration of both acute and late tissue toxicities in exposed victims....
9.
Moulder J, Cohen E, Medhora M, Fish B
Life Sci Space Res (Amst)
. 2022 Nov;
35:60-68.
PMID: 36336371
Angiotensin converting enzyme (ACE) inhibitors are effective countermeasures to chronic radiation injuries in rodent models, and there is evidence for similar effects in humans. In rodent models ACE inhibitors are...
10.
Gasperetti T, Sharma G, Frei A, Pierce L, Veley D, Szalewski N, et al.
Radiat Res
. 2022 Jul;
198(4):325-335.
PMID: 35904437
The renin-angiotensin system (RAS) is known to regulate the pathogenesis of radiation-induced injury as inhibitors of the RAS enzyme angiotensin converting enzyme (ACE) have established function as mitigators of multi-organ...